Trinity Capital exits Core Scientific equity position, realizes 17.7% IRR on $30M financing

Trinity Capital Inc.

Trinity received 5,640,373 Core Scientific shares in satisfaction of $28.3M bankruptcy claim.
Shares sold at weighted avg price of $5.13/share, generating $29.0M in proceeds.
17.7% internal rate of return on original $30M equipment financing provided in 2021.
Core Scientific entered Chapter 11 in Dec 2022 and exited bankruptcy in Jan 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.